Home
Resources
Publications
Almond Oil for Patients With Hyperlipidemia: A Randomized Open-Label Controlled Clinical Trial

Almond Oil for Patients With Hyperlipidemia: A Randomized Open-Label Controlled Clinical Trial

Mohammad Javad Zibaeenezhad, Parham Ostovan, Seyed Hamdollah Mosavat, Mahmood Zamirian, Armin Attar

Complement Ther Med. 2019 Feb;42:33-36.

PMID: 30670262

Abstract:

Background:
Cardiovascular diseases currently account for nearly half of non-communicable diseases. It was shown that enjoying a handful of nuts every day can significantly reduce the risk of developing heart diseases as they contain a variety of nutrients and other bioactive substances contributing to lowering the risk of heart diseases and controlling the cholesterol. The aim of this study was to determine the effect of almond oil on the lipid profile of patients with hyperlipidemia.
Methods:
Ninety-seven patients were divided into the intervention (n = 49) and control (n = 48) groups. The intervention group received 10 ml of almond oil two times daily for 30 days. There was no intervention for the control group. The serum lipoproteins were measured before and after the study.
Results:
The total cholesterol and LDL levels decreased significantly in the intervention group (treatment difference = -16.12 ± 26.16, P = 0.009; treatment difference = -20.88 ± 18.4, p < 0.001 respectively). But regular almond oil consumption did not significantly affect the triglyceride and HDL in this sample of hyperlipidemic patients.
Conclusion:
Consumption of almond could reduce the total cholesterol and LDL in dyslipidemic patients.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP8007690	Almond oil		8007-69-0	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: